BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8966190)

  • 1. Interferon-alpha 2b increases fibrolysis in fibrotic livers from bile duct ligated rats: possible participation of the plasminogen activator.
    Rodríguez-Fragoso L; González MP; Muriel P
    Pharmacology; 1995 Dec; 51(6):341-6. PubMed ID: 8966190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat.
    Muriel P
    J Hepatol; 1996 May; 24(5):614-21. PubMed ID: 8773918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of S-adenosyl-L-methionine and interferon-alpha2b on liver damage induced by bile duct ligation in rats.
    Muriel P; Castro V
    J Appl Toxicol; 1998; 18(2):143-7. PubMed ID: 9570697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity.
    Bueno MR; Daneri A; Armendáriz-Borunda J
    J Hepatol; 2000 Dec; 33(6):915-25. PubMed ID: 11131453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha preserves erythrocyte and hepatocyte ATPase activities from liver damage induced by prolonged bile duct ligation in the rat.
    Muriel P
    J Appl Toxicol; 1995; 15(6):449-53. PubMed ID: 8603932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo inefficiency of pentoxifylline and interferon-alpha on hepatic fibrosis in biliary-obstructed rats: assessment by tissue collagen content and prolidase activity.
    Tarçin O; Avşar K; Demirtürk L; Gültepe M; Oktar BK; Ozdoğan OC; Tarçin O; Baloğlu H; Gürbüz AK
    J Gastroenterol Hepatol; 2003 Apr; 18(4):437-44. PubMed ID: 12653893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethylcolchicinic acid decreases liver fibrosis and cholestasis induced by prolonged biliary obstruction in the rat.
    Muriel P; Ostoa-Saloma PU; Reyes-Esparsa JA; Rodríguez-Fragoso L
    J Appl Toxicol; 1997; 17(3):145-51. PubMed ID: 9250535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of liver fibrosis by interferon-alpha 2b.
    Moreno MG; Muriel P
    Biochem Pharmacol; 1995 Aug; 50(4):515-20. PubMed ID: 7646558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.
    Abdel-Aziz G; Lebeau G; Rescan PY; Clément B; Rissel M; Deugnier Y; Campion JP; Guillouzo A
    Am J Pathol; 1990 Dec; 137(6):1333-42. PubMed ID: 2260623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sho-saiko-to prevents liver fibrosis induced by bile duct ligation in rats.
    Chen MH; Chen JC; Tsai CC; Wang WC; Chang DC; Lin CC; Hsieh HY
    Am J Chin Med; 2004; 32(2):195-207. PubMed ID: 15315258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations.
    Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U
    J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix proteins of basement membrane of intrahepatic bile ducts are degraded in congenital hepatic fibrosis and Caroli's disease.
    Yasoshima M; Sato Y; Furubo S; Kizawa K; Sanzen T; Ozaki S; Harada K; Nakanuma Y
    J Pathol; 2009 Feb; 217(3):442-51. PubMed ID: 19025978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halofuginone can worsen liver fibrosis in bile duct obstructed rats.
    Van de Casteele M; Roskams T; Van der Elst I; van Pelt JF; Fevery J; Nevens F
    Liver Int; 2004 Oct; 24(5):502-9. PubMed ID: 15482349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response studies of interferon-alpha 2b on liver fibrosis and cholestasis induced by biliary obstruction in rats.
    Muriel P; Castro V
    Pharmacology; 1997 Apr; 54(4):179-85. PubMed ID: 9211563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
    Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
    World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
    Younis N; Shaheen MA; Abdallah MH
    Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of interferon-alpha on the mRNA expression of procollagen type I and III of hepatic stellate cells and on the deposition of collagen type I and III in fibrotic liver of rats].
    Zhang Q; Wang J; Hu M
    Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):695-8. PubMed ID: 11715461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of apoptosis in the remodeling of cholestatic liver injury following release of the mechanical stress.
    Costa AM; Tuchweber B; Lamireau T; Yousef IM; Balabaud C; Rosenbaum J; Desmoulière A
    Virchows Arch; 2003 Apr; 442(4):372-80. PubMed ID: 12715172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K1 attenuates bile duct ligation-induced liver fibrosis in rats.
    Jiao K; Sun Q; Chen B; Li S; Lu J
    Scand J Gastroenterol; 2014 Jun; 49(6):715-21. PubMed ID: 24742111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats.
    Aksu B; Umit H; Kanter M; Guzel A; Aktas C; Civelek S; Uzun H
    Acta Histochem; 2010 May; 112(3):259-69. PubMed ID: 19217652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.